WebApr 9, 2024 · Shares of Prometheus Biosciences stock opened at $112.86 on Friday. Prometheus Biosciences, Inc. has a 1 year low of $21.50 and a 1 year high of $129.60. The company has a debt-to-equity ratio of ... WebApr 12, 2024 · Prometheus Biosciences Stock Up 0.5 %. NASDAQ RXDX opened at $113.97 on Wednesday. The stock has a market cap of $5.42 billion, a PE ratio of -32.75 and a beta of -0.60. Prometheus Biosciences ...
RXDX: Prometheus Biosciences Inc Stock Price Quote
WebGet Prometheus Biosciences Inc (RXDX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebFeb 28, 2024 · The stock of Prometheus Biosciences has tripled since positive mid-stage trial results for its primary candidate for treating UC and CD came out in early December. Since then the company has done ... epworth school calendar
Prometheus Biosciences Inc (RXDX) Stock Price & News
WebMar 8, 2024 · Prometheus Biosciences was founded in 2016 and booked $1 million in collaboration revenue for the 12 months ended December 31, 2024. It plans to list on the Nasdaq under the symbol RXDX. SVB ... Web2 days ago · Prometheus Biosciences (RXDX) Stock Price & Analysis 156 RXDX Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range $21.50 - $129.60 Previous Close $111.29 Volume 166.32K Average Volume (3M) 511.11K Market Cap $4.99B Enterprise Value $4.62B Total Cash (Recent Filing) $695.75M Total Debt (Recent Filing) … WebDec 9, 2024 · Prometheus Biosciences (NASDAQ:RXDX) stock soared nearly 225% in the past two days and hit $117.73 for the first time since going public in March 2024.Positive Phase-2 trial results for its PRA023 drug, designed to treat ulcerative colitis and Crohn’s disease, supported the rally.. As the next step, Prometheus CEO Mark McKenna said, “We … epworth school address